Skip to search formSkip to main contentSkip to account menu

acarboxy prothrombin

Known as: pre-blood-coagulation factor II, descarboxylated prothrombin, descarboxyprothrombin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Sorafenib is an effective treatment for unresectable hepatocellular carcinoma (HCC) characterized by disease stabilization… 
2009
2005
2005
Summary21 Patients with normal and impaired renal function were given cefoperazone in a recommended dose of 4 g/day, irrespective… 
2003
2003
BACKGROUND Hepatocellular carcinoma (HCC) is one of the world's major malignancies, especially in Asian countries. To improve the… 
1997
1997
We investigated various pharmacokinetic and pharmacodynamic parameters in a 63-year-old man, resistant to warfarin, fluindione… 
1992
1992
Summary Assessments of the vitamin K status in newborns and their mothers by means of des-γ-carboxy-prothrombin (PIVKA II… 
1980
1980
After the platelet release reaction, factor Xa binds to a receptor on the platelet surface with high affinity, Ka 5.2 × 1o9 M−1… 
1978
1978
The formation of vitamin K epoxide and the vitamin K-dependent carboxylation of glutamic acid residues present in synthetic…